GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Policy Acquisition Expense

Stealth BioTherapeutics (Stealth BioTherapeutics) Policy Acquisition Expense


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.